Commentary: Circulating tumor DNA in resectable non-small cell lung cancer: Emerging canary in the coal mine

被引：0
|
作者：
Sachdeva, Uma M. [1 ]
机构：
[1] Massachusetts Gen Hosp, Div Thorac Surg, 55 Fruit St, Austen 7, Boston, MA 02114 USA
来源：
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2024年 / 168卷 / 05期
关键词：
D O I：
10.1016/j.jtcvs.2024.03.022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The expanding role of circulating tumor DNA in resectable non-small cell lung cancer
    Morgensztern, Daniel
    CANCER, 2024, 130 (10) : 1730 - 1732
  • [2] Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer
    Abbosh, Chris
    Hodgson, Darren
    Doherty, Gary J.
    Gale, Davina
    Black, James R. M.
    Horn, Leora
    Reis-Filho, Jorge S.
    Swanton, Charles
    TRENDS IN CANCER, 2024, 10 (07) : 643 - 654
  • [3] Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer
    Marmarelis, Melina
    Thompson, Jeffrey C.
    Aggarwal, Charu
    Evans, Tracey L.
    Carpenter, Erica
    Cohen, Roger B.
    Langer, Corey J.
    Bauml, Joshua
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (18)
  • [4] Detection and application of circulating tumor cell and circulating tumor DNA in the non-small cell lung cancer
    Zhang, Yuting
    Zheng, Hongmei
    Zhan, Yuting
    Long, Mengping
    Liu, Sile
    Lu, Junmi
    Zang, Hongjing
    Fan, Songqing
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (12): : 2377 - 2386
  • [5] Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
    Yang, Jialiang
    Hui, Yan
    Zhang, Yanxiang
    Zhang, Minghui
    Ji, Binbin
    Tian, Geng
    Guo, Yangqiang
    Tang, Min
    Li, Lianxing
    Guo, Bella
    Ma, Tonghui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Circulating tumor DNA testing in advanced non-small cell lung cancer
    Moding, Everett J.
    Diehn, Maximilian
    Wakelee, Heather A.
    LUNG CANCER, 2018, 119 : 42 - 47
  • [7] Circulating Tumor DNA as a Biomarker in Oligometastatic Non-small Cell Lung Cancer
    Lebow, E. S.
    Murciano-Goroff, Y.
    Razavi, P.
    Reis-Filho, J. S.
    Flynn, J.
    Zhang, Z.
    Tu, H. Y.
    Bertucci, C.
    Lim, L. P.
    Li, M.
    Drilon, A.
    Riely, G.
    Rudin, C. M.
    Jones, D.
    Yang, T. J.
    Rimner, A.
    Arcila, M. E.
    Isbell, J.
    Li, B. T.
    Gomez, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S174 - S174
  • [8] The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer
    Dunne, Elizabeth G.
    Fick, Cameron N.
    Isbell, James M.
    Chaft, Jamie E.
    Altorki, Nasser
    Park, Bernard J.
    Spicer, Jonathan
    Forde, Patrick M.
    Gomez, Daniel
    Iyengar, Puneeth
    Harpole Jr, David H.
    Stinchcombe, Thomas E.
    Liberman, Moishe
    Bott, Matthew J.
    Adusumilli, Prasad S.
    Huang, James
    Rocco, Gaetano
    Jones, David R.
    ANNALS OF THORACIC SURGERY, 2024, 118 (01): : 119 - 129
  • [9] Circulating tumor DNA analysis integrating tumor clonality detects minimal residual disease in resectable non-small cell lung cancer
    Yin, R.
    Wang, S.
    Wu, M.
    Li, M.
    Bao, H.
    Jiang, F.
    Wang, J.
    Wu, X.
    Shao, Y.
    Xu, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S932 - S932
  • [10] Serum tumor markers in resectable and non-resectable non-small cell lung cancer
    Nisman, B
    Heching, N
    Barak, V
    JOURNAL OF TUMOR MARKER ONCOLOGY, 2000, 15 (03): : 195 - 207
12345